Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome (2014)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1186/1758-5996-6-79
- Subjects: INFLAMAÇÃO; FATORES DE RISCO; TABAGISMO; DOENÇAS CARDIOVASCULARES; SÍNDROME X METABÓLICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Diabetology and Metabolic Syndrome
- ISSN: 1758-5996
- Volume/Número/Paginação/Ano: v. 6, n. 79, p. (online), 2014
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
JAMAL, Omar et al. Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome. Diabetology and Metabolic Syndrome, v. 6, n. 79, p. (online), 2014Tradução . . Disponível em: https://doi.org/10.1186/1758-5996-6-79. Acesso em: 14 abr. 2026. -
APA
Jamal, O., Aneni, E. C., Shaharyar, S., Ali, S. S., Parris, D., McEvoy, J. W., et al. (2014). Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome. Diabetology and Metabolic Syndrome, 6( 79), (online). doi:10.1186/1758-5996-6-79 -
NLM
Jamal O, Aneni EC, Shaharyar S, Ali SS, Parris D, McEvoy JW, Veledar E, Blaha MJ, Blumenthal RS, Agatston AS, Conceição RD, Feldman T, Carvalho JA, Santos RD, Nasi K. Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome [Internet]. Diabetology and Metabolic Syndrome. 2014 ; 6( 79): (online).[citado 2026 abr. 14 ] Available from: https://doi.org/10.1186/1758-5996-6-79 -
Vancouver
Jamal O, Aneni EC, Shaharyar S, Ali SS, Parris D, McEvoy JW, Veledar E, Blaha MJ, Blumenthal RS, Agatston AS, Conceição RD, Feldman T, Carvalho JA, Santos RD, Nasi K. Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome [Internet]. Diabetology and Metabolic Syndrome. 2014 ; 6( 79): (online).[citado 2026 abr. 14 ] Available from: https://doi.org/10.1186/1758-5996-6-79 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
- Evolocumab in pediatric heterozygous familial hypercholesterolemia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
